Literature DB >> 4461792

Monamine oxidase in schizophrenia and other behavioral disorders.

D L Murphy, R Belmaker, R J Wyatt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4461792     DOI: 10.1016/0022-3956(74)90097-1

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


× No keyword cloud information.
  11 in total

1.  Monoamine oxidase activity in different density gradient fractions of human platelets.

Authors:  D L Murphy; J L Costa; B Shafer; L Corash
Journal:  Psychopharmacology (Berl)       Date:  1978-10-31       Impact factor: 4.530

2.  Effect of neurocatin on the activity of monoamine oxidase B in rat brain synaptosomes.

Authors:  S Murphy; A Pastuszko
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

3.  Comparative behavioral effects of clorgyline and pargyline in man: a preliminary evaluation.

Authors:  S Lipper; D L Murphy; S Slater; M S Buchsbaum
Journal:  Psychopharmacology (Berl)       Date:  1979-04-11       Impact factor: 4.530

4.  Platelet monoamine oxidase activity in first-degree relatives of schizophrenic patients.

Authors:  P Propping; W Friedl
Journal:  Psychopharmacology (Berl)       Date:  1979-11       Impact factor: 4.530

5.  Inhibition of monoamine oxidases by haloperidol and its metabolites: pharmacological implications for the chemotherapy of schizophrenia.

Authors:  J Fang; P H Yu; J W Gorrod; A A Boulton
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

6.  Molecular properties of monoamine oxidases A and B.

Authors:  S W Kwan; J M Bergeron; C W Abell
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Individual differences in average evoked responses to d- and l-amphetamine with and without lithium carbonate in depressed patients.

Authors:  M S Buchsbaum; D P van Kammen; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1977-01-31       Impact factor: 4.530

8.  Monoamine oxidase activity and enzyme kinetics in three subpopulations of density-fractionated platelets in chronic paranoid schizophrenics.

Authors:  J J Mann; R D Kaplan; A Georgotas; E Friedman; M Branchey; S Gershon
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

9.  Low platelet MAO activity in chronic schizophrenics: a long-term effect of neuroleptic treatment?

Authors:  M Del Vecchio; M Maj; A D'Ambrosio; D Kemali
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

10.  Substrate-typic changes of platelet monoamine oxidase activity in sub-types of schizophrenia.

Authors:  L Demisch; H von der Mühlen; H J Bochnik; N Seiler
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1977-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.